The Enterprise Value as of December 2025 (TTM) for Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) is 723.16M

According to Aspira Pathlab & Diagnostics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 723.16M. This represents a change of 5.74% compared to the average of 683.90M of the last 4 quarters.

Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) Historical Enterprise Value (quarterly & annually)

How has ASPIRA.BO Enterprise Value performed in the past?

The mean historical Enterprise Value of Aspira Pathlab & Diagnostics Limited over the last ten years is 353.40M. The current 723.16M Enterprise Value has changed 20.36% with respect to the historical average. Over the past ten years (40 quarters), ASPIRA.BO's Enterprise Value was at its highest in in the March 2025 quarter at 845.48M. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aspira Pathlab & Diagnostics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) Average Enterprise Value

How has ASPIRA.BO Enterprise Value performed in the past?

The current Enterprise Value of Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) Enterprise Value vs. Peers

How is ASPIRA.BO’s Enterprise Value compared to its peers?

Aspira Pathlab & Diagnostics Limited’s Enterprise Value is greater than Choksi Imaging Limited (686.39M), greater than Biofil Chemicals and Pharmaceuticals Limited (545.63M), greater than Vivo Bio Tech Limited (511.22M), greater than Biofil Chemicals and Pharmaceuticals Limited (545.63M), greater than Medinova Diagnostic Services Limited (452.32M), greater than Rajnish Wellness Limited (474.01M), greater than Vista Pharmaceuticals Limited (602.58M), greater than N G Industries Ltd. (419.09M), greater than Vasundhara Rasayans Limited (601.00M), less than Godavari Drugs Limited (1.25B),

Build a custom stock screener for Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aspira Pathlab & Diagnostics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aspira Pathlab & Diagnostics Limited (ASPIRA.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aspira Pathlab & Diagnostics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.